Tonen-Wolyec Serge, Muwonga Masidi Jérémie, Kamanga Lukusa Luc Ferdinand, Nsiku Dikumbwa Gaetan, Sarassoro Angèle, Bélec Laurent
Ecole Doctorale Régionale D'Afrique Centrale en Infectiologie Tropicale, Franceville, Gabon.
Faculty of Medicine and Pharmacy, University of Kisangani, Kisangani, Democratic Republic of the Congo.
Open Forum Infect Dis. 2020 Nov 29;7(12):ofaa554. doi: 10.1093/ofid/ofaa554. eCollection 2020 Dec.
The Democratic Republic of the Congo (DRC) has begun implementing HIV self-testing to boost the first "95" of the UNAIDS 95-95-95 targets by 2025. This study aims to assess the performance and usability of the Exacto Test HIV (Biosynex, Strasbourg, France) self-test in the lab and in the field. The Exacto Test HIV self-test demonstrated high virological performance (sensitivity, 99.6%; specificity, 100%) in the lab and in the field in the hand of untrained users (sensitivity, 100%; specificity, 98.9%). Taken together, the excellent performance and usability characteristics of the Exacto Test HIV (Biosynex) self-test make the kit a viable option for HIV self-testing in the DRC.
刚果民主共和国（DRC）已开始实施艾滋病毒自我检测，以在2025年前推动实现联合国艾滋病规划署95-95-95目标中的首个“95”。本研究旨在评估Exacto Test HIV（法国斯特拉斯堡的Biosynex公司）自我检测在实验室及现场的性能和易用性。Exacto Test HIV自我检测在实验室以及未经培训的使用者现场操作中均表现出较高的病毒学性能（敏感性为99.6%；特异性为100%），现场操作时敏感性为100%，特异性为98.9%。总体而言，Exacto Test HIV（Biosynex）自我检测出色的性能和易用性特点使其成为刚果民主共和国艾滋病毒自我检测的一个可行选择。
